News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2
Photo from Chul Kim/X
Apr 26, 2024, 09:26

Chul Kim: Thoughtful discussion and great talk by Rachel Sanborn about recent approval of FLAURA2

Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X/Twitter:

”First-line treatment for EGFR mutant NSCLC is getting complex with recent approval of FLAURA2.

Would higher risk populations benefit more (e.g. L858R, co-mutations including TP53, RB1, CNS met)?

Thoughtful discussion and great talk by Rachel Sanborn.”

Chul Kim/X

Source: Chul Kim/X

 

cancer Chul Kim EGFR-mutant NSCLC EGFR-mutation FLAURA2 Georgetown University Lung cancer non small cell lung cancer NSCLC OncoDaily Oncology Rachel Sanborn Texas Lung Cancer Conference
Special Coverage
Insight
Dec 30, 2024, 12:39
When Diversity Goals Meet Multiregional Trials by Gautam Mehta et al. - FDA Oncology
Blog
Dec 30, 2024, 12:36
Jean Kaseya: No one serving humanity should endure violence
Insight
Dec 30, 2024, 12:33
Patrick Hwu: Why treating neurological disorders like brain tumors is difficult
Insight
Dec 30, 2024, 12:29
Laura Bukavina: No significant link was found between plant-based or animal-based protein intake and bladder cancer risk
Science
Dec 30, 2024, 12:25
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer
Science
Dec 30, 2024, 12:08
Nicholas Short: Measurable residual disease monitoring in AML
Blog
Dec 30, 2024, 12:06
Michael Hofman: Honoring Felix Feng
Science
Dec 30, 2024, 12:03
Misty Dawn Shields: Rare lung cancers have a paucity of info and they aren’t in first place
Science
Dec 30, 2024, 11:56
Anirban Maitra: The highest cited publication overall is a review on Pancreatic Cancer
Insight
Dec 30, 2024, 11:25
Shane Jacobson: The V Foundation is launching a search for Senior (executive) Leadership Team
Insight
Dec 30, 2024, 11:19
Anirban Maitra: An Open Access review on current status of KRAS inhibitors, resistance drivers and potential combinations
Insight
Dec 30, 2024, 11:16
Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification